AMP Global 2019 Video Series Part 1 of 4Invivoscribe Marketing2022-05-25T03:01:01-07:00May 16th, 2019|2019 Videos, Featured Videos, Videos| Watch video
Establishment of Immunoglobulin Heavy (IGH) Chain Clonality Testing by Next-Generation Sequencing for Routine Characterization of B-Cell and Plasma Cell NeoplasmsInvivoscribe Marketing2021-02-11T23:46:14-08:00March 21st, 2019|2019 Publications, Featured Publications, Publications| Read more
US FDA approves Invivoscribe LeukoStrat CDx FLT3 Mutation Assay as CDx and Astellas drug XOSPATA (gilteritinib fumarate) for treatment of AML patients in the USInvivoscribe also Receives National Reimbursement for CDx Assay in JapanInvivoscribe Marketing2021-02-26T19:11:02-08:00November 29th, 2018|2018 Press Releases, Press Releases| Read more
Invivoscribe Submits LeukoStrat CDx FLT3 Mutation Assay both in the US and Japan to Support Daiichi Sankyo Submissions for QuizartinibInvivoscribe Marketing2022-09-23T16:52:06-07:00November 27th, 2018|2018 Press Releases, Press Releases| Read more
Invivoscribe Submits the LeukoStrat CDx FLT3 Mutation Assay to Support Daiichi Sankyo Submission for Quizartinib in JapanInvivoscribe Marketing2021-02-26T19:11:48-08:00November 19th, 2018|2018 Press Releases, Press Releases| Read more
Invivoscribe® Receives Approval in Japan for its LeukoStrat® CDx FLT3 Mutation Assay to Assess Acute Myeloid Leukemia (AML) Patients Eligible for Treatment with Xospata® (gilteritinib fumarate)Invivoscribe Marketing2021-02-26T19:12:02-08:00September 27th, 2018|2018 Press Releases, Press Releases| Read more
A next-generation sequencing–based assay for minimal residual disease assessment in AML patients with FLT3-ITD mutationsInvivoscribe Marketing2021-02-11T23:49:39-08:00August 25th, 2018|2018 Publications, Featured Publications, Publications| Read more
Simple deep sequencing-based post-remission MRD surveillance predicts clinical relapse in B-ALLInvivoscribe Marketing2021-02-11T23:54:51-08:00August 22nd, 2018|2018 Publications, Featured Publications, Publications| Read more
Invivoscribe Announces a Regional “Center of Excellence” Reference Laboratory in Beirut to Offer Specialized Gene PanelsInvivoscribe Marketing2021-02-26T19:12:15-08:00May 9th, 2018|2018 Press Releases, Press Releases| Read more
Invivoscribe Submits Pre-Market Approval Application in Japan and Panel Track Supplement in the US to Screen Acute Myeloid Leukemia (AML) Patients for FLT3 MutationsInvivoscribe Marketing2021-02-26T19:12:23-08:00May 8th, 2018|2018 Press Releases, Press Releases| Read more
Clinical-scale Rapid Autologous BK-virus Specific T Cell Line generation from Kidney Transplant Recipients with Active Viremia for Adoptive ImmunotherapyInvivoscribe Marketing2021-02-12T21:23:31-08:00November 11th, 2017|2017 Publications, Publications| Read more
Minimal Residual Disease (MRD) Status Following Induction Chemo-Immunotherapy Predicts Progression-Free Survival In Mantle Cell Lymphoma (MCL): CALGB 50403 (Alliance)Invivoscribe Marketing2021-02-12T00:14:15-08:00August 9th, 2017|2017 Publications, Publications| Read more
Detection of Immunoglobulin Heavy Chain Gene Clonality by Next-Generation Sequencing for Minimal Residual Disease Monitoring in B-Lymphoblastic LeukemiaInvivoscribe Marketing2021-02-12T00:59:47-08:00July 3rd, 2017|2017 Publications, Publications| Read more
In vitro co-expression of human amyloidogenic immunoglobulin light and heavy chain proteins: a relevant cell-based model of AL amyloidosisInvivoscribe Marketing2021-02-12T01:06:38-08:00June 20th, 2017|2017 Publications, Publications| Read more
Phenotypic and functional characterization of T cells in white matter lesions of multiple sclerosis patientsInvivoscribe Marketing2021-02-12T00:57:59-08:00June 17th, 2017|2017 Publications, Publications| Read more
T and B cell clonal expansion in Ras associated lymphoproliferative disease (RALD) as revealed by next generation sequencingInvivoscribe Marketing2021-02-12T00:17:56-08:00May 30th, 2017|2017 Publications, Publications| Read more
Molecular pathology diagnosis of diffuse large B cell lymphoma using BIOMED-2 clonal gene rearrangementsInvivoscribe Marketing2021-02-12T01:03:26-08:00April 27th, 2017|2017 Publications, Publications| Read more
A Small Case Series of Intravascular Large B-Cell Lymphoma with Unexpected Findings: Subset of Cases with Concomitant Extravascular Central Nervous System (CNS) Involvement Mimicking Primary CNS LymphomaInvivoscribe Marketing2021-02-12T01:10:12-08:00April 17th, 2017|2017 Publications, Publications| Read more
Targeted Deep Sequencing Reveals Clinically Relevant Subclonal IgHV Rearrangements in Chronic Lymphocytic LeukemiaInvivoscribe Marketing2021-02-12T18:36:01-08:00October 31st, 2016|2016 Publications, Featured Publications, Publications| Read more
Breast Implant-Associated Anaplastic Large Cell Lymphoma: Two Distinct Clinicopathological Variants with Different OutcomesInvivoscribe Marketing2021-02-12T22:19:56-08:00February 1st, 2016|2016 Publications, Publications| Read more
Discordant Lymphoma Consisting of Mediastinal Large B-Cell Lymphoma and Nodular Sclerosis Hodgkin Lymphoma in the Right Supraclavicular Lymph Nodes: A Case ReportInvivoscribe Marketing2021-02-12T22:24:11-08:00December 29th, 2015|Archived Publications, Publications| Read more
Molecular Genetic Data Favoring a Sequential Clonal Transformation of a Large B Cell Lymphoma into an Anaplastic Large T Cell Lymphoma, ALK-NegativeInvivoscribe Marketing2021-02-12T20:48:04-08:00December 1st, 2015|Archived Publications, Publications| Read more
Mucosal CD30-Positive T-Cell Lymphoproliferative Disorder Arising in the Oral Cavity Following Dental ImplantsInvivoscribe Marketing2021-02-12T22:28:17-08:00August 10th, 2015|Archived Publications, Publications| Read more
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in chronic lymphocytic leukemiaInvivoscribe Marketing2021-02-13T00:38:16-08:00March 18th, 2015|Archived Publications, Publications| Read more
Deep sequencing reveals clonal evolution patterns and mutation events associated with relapse in B-cell lymphomasInvivoscribe Marketing2021-02-13T00:42:37-08:00August 15th, 2014|Archived Publications, Publications| Read more